You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

June 23, 2020

Updated Deposit-on-Arrival Information and Pricing Policy for Foreign Travelers to Cambodia

On June 11, the Ministry of Health (MOH) released a notice on an updated pricing policy for COVID-19 tests, quarantine, and treatment services for foreign travelers arriving in Cambodia. This served to update and further detail an MOH announcement made on June 8 requiring that all foreign travelers entering Cambodia pay a deposit of USD 3,000 to designated commercial banks upon arrival at airports. This requirement was implemented on Monday, June 15, and is meant to ensure that all foreign travelers are able to pay for any required COVID-19 tests and other healthcare.

The June 8 announcement notes that the deposit can be made by cash or credit card, though initial reports indicate that payment methods are currently limited to cash and electronic funds transfer. Travelers who are unable to pay the deposit upon arrival could face immediate deportation. After the passage of the two-week quarantine or other relevant period, travelers may collect the remaining portion of their deposit that was not spent on necessary tests, quarantine facilities, transportation, and other services.

The June 11 notice outlined a payment structure for three potential subsets of travelers: those who quarantine upon arrival solely for the length of time necessary to obtain their negative COVID-19 test results, those who are forced to quarantine for 14 days due to being in proximity to a traveler on the same flight who tested positive for COVID-19, and those who test positive for COVID-19 upon arrival and must seek medical attention.

Fees for Foreigners Waiting for Initial COVID-19 Test Results

The pricing structure for services provided to foreign travelers includes transport from the airport to an isolation facility (USD 5), one COVID-19 test upon arrival and another within two weeks of arrival (USD 100 per test), lodging at designated hotels and quarantine centers (USD 30 per day), and three meals each day (USD 30 per day).

The designated hotels and quarantine centers, according to informal reports, include the Tian Yi International Hotel, Hotel Kolab Sor, and OK Boutique Hotel in Phnom Penh. Travelers do not have the option of choosing the hotel in which they would prefer to quarantine. Some hotels’ rates for meals and accommodations have been reported, and they differ slightly from the rates shared in the June 11 notice. According to unofficial reports, hotels are mandating double occupancy for each quarantine-designated room—even for solo travelers.

If all passengers test negative for COVID-19 upon arrival in Cambodia, their passports will be returned and they will be released from government custody. However, all are expected to self-isolate for the following two weeks. MOH self-isolation guidelines entail wearing a mask, refraining from leaving accommodations unless necessary, and physical distancing of approximately two meters. After 13 days in Cambodia, travelers should visit either the Khmer-Soviet Friendship Hospital in Phnom Penh or a provincial referral hospital for follow-up tests to confirm the absence of COVID-19.

The following official costs will be applicable to all foreign travelers arriving in Cambodia:

Fees for Government-Enforced Quarantine

If any traveler tests positive for COVID-19 upon arrival, all passengers on the same flight will be required to quarantine at designated government centers or hotels.

In the event of an enforced 14-day quarantine, the daily rates from the waiting period will continue and the following additional fees will be chargeable:

Therefore, including the room and board costs detailed earlier, for those travelers who test negative for COVID-19 upon arrival but who were on the same flight as someone who tested positive, a 14-day enforced quarantine at a designated facility is priced at approximately USD 84 per day.

Fees for COVID-19 Treatment in a Public Hospital

For those foreign travelers who test positive for COVID-19 upon arrival in Cambodia, a minimum of four COVID-19 tests (priced at USD 100 per test) must be administered, and each patient must pay USD 75 per day for lodging, food, and laundry services. The following associated fees may also apply:

The MOH has reiterated that, in addition to the USD 3,000 deposit, all foreign travelers to Cambodia are required to provide proof of health insurance providing coverage in Cambodia for up to USD 50,000, as well as an original and official medical certificate (signed and sealed with a stamp, certifying that the traveler is negative for COVID-19) issued within 72 hours of flying to Cambodia.

Travelers should also note that there has been confusion regarding the parameters of the 72-hour requirement. Some airlines have prevented travelers from boarding their flights to Cambodia because they would not arrive in Cambodia within 72 hours of their initial COVID-19 tests. The Cambodian embassy in Washington, DC, has indicated that it would defer to airlines’ judgment on interpreting the MOH requirements for travel. Travelers should therefore contact their airline for particulars on requirements.

RELATED INSIGHTS​ 

October 30, 2023
A Resounding Victory The last days of October brought some excitement for one of the leading pharmaceutical companies in the world, Novartis, when its patent litigation case in Vietnam against a local generic manufacturer, which had stretched over more than eight years, finally came to an end. The background of this case is quite simple. Novartis was the owner of a patent protecting the active ingredient vildagliptin, which was commercialized through its Galvus® product, a medicine used to treat type 2 diabetes. In 2015, the company found that a drug manufacturer in Vietnam’s Binh Duong province on the outskirts of Ho Chi Minh City was producing a medicinal product containing the vildagliptin active ingredient—an infringement of its patent. Novartis first submitted a request to the Ministry of Science and Technology (MOST) to apply administrative sanctions on this infringer. Subsequently, the MOST Inspectorate concluded in July 2015 that the defendant had committed patent infringement and ordered them to stop producing the infringing drugs and recall them from the market. However, the defendant did not comply with the conclusion, and sought an appeal while it continued to produce the infringing medicine. Realizing that administrative sanctions were not strict enough to deter the defendant, Novartis continued to protect its legitimate rights and interests by initiating a lawsuit at the provincial court where the defendant was headquartered, Binh Duong. Novartis claimed that the defendant had infringed the patent and requesting the defendant to compensate for damages at the highest level allowed by law, pay attorney fees, and publicly apologize to Novartis in specialized newspapers. This began a long journey full of challenges that finally ended with the second appellate judgment declared by the High People’s Court of Ho Chi Minh City on October 17, 2023. The court accepted all claims raised by the
August 25, 2023
Michael Ramirez, a counsel in Tilleke & Gibbins’ dispute resolution department, has contributed an article to a series on contractual terms in Asia from the Asian Business Law Institute. Previous articles in the series have looked at administrative and tax requirements and contract breach and remedy under Thai law. The article gives an overview of how extracontractual liabilities are treated under Thai law. It addresses issues related to contract negotiations, no-reliance clauses, entire agreement clauses, and concurrent liability. ABLI, which is based in Singapore, conducts legal research and dissemination in order to provide knowledge, guidance, and recommendations surrounding development of legal systems in Asia. The full article on extracontractual liabilities is available as a PDF through the button below.
August 23, 2023
Introduction The idea of the metaverse rose to prominence in the public discourse in 2021, most notably when Facebook renamed itself Meta and announced a new focus on launching a virtual, immersive world. The initial excitement around the metaverse has since faded, with worsening economic conditions having a particularly acute effect on companies in the technology sector. When Meta CEO Mark Zuckerberg announced in March 2023 that artificial intelligence (AI) was the company’s “single largest investment,” many took this as a sign of the company shifting focus away from the metaverse. However, there remains significant interest in the metaverse from both businesses and consumers. Zuckerberg himself reaffirmed Meta’s focus on the metaverse, highlighting how developments in AI will improve virtual reality (VR) and augmented reality (AR) technology. Meanwhile, Roblox, a metaverse gaming platform, announced that in Q1 2023, its number of daily active users had increased to 66 million. Most recently, the announcement by Apple of its new ‘Vision Pro’ AR headset is reported to have renewed interest in the metaverse among developers. A particular area of interest in the developing metaverse is digital fashion and retail. In its Metaverse Fashion Trends Report 2022, Roblox found that nearly three in four users aged 14 to 24 spend money on digital fashion items. Roblox itself has partnered with fashion brands Burberry, Gucci, Tommy Hilfiger, and others, to offer experiences and items for use on the platform. In March 2023, Decentraland, a metaverse platform with a decentralized governance structure, hosted the Metaverse Fashion Week, featuring brands such as Adidas, Coach, and DKNY. As businesses continue to invest and look for opportunities to expand into the metaverse, whether through traditional e-commerce or more innovative digital asset offerings, it is important that they consider the ways in which new and existing laws apply
August 3, 2023
Tilleke & Gibbins’ insurance specialists in Cambodia, Laos, Myanmar, and Thailand have contributed to the Law and Jurisdiction in Insurance and Reinsurance Contracts – Asia Pacific guide produced by RPC. The guide addresses how governing law, jurisdiction, and arbitration clauses are used in insurance and reinsurance contracts. For each jurisdiction in the Asia Pacific region, the guide addresses the following topics: Governing law; Arbitration; Mediation; and Limitations and time bars on claims. The Law and Jurisdiction in Insurance and Reinsurance Contracts – Asia Pacific guide is available below.